{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T16:47:38Z","timestamp":1773420458706,"version":"3.50.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Ministry of Health Labor and Welfare"},{"DOI":"10.13039\/100009666","name":"Salt Science Research Foundation","doi-asserted-by":"crossref","award":["1026"],"award-info":[{"award-number":["1026"]}],"id":[{"id":"10.13039\/100009666","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009666","name":"Salt Science Research Foundation","doi-asserted-by":"crossref","award":["1228"],"award-info":[{"award-number":["1228"]}],"id":[{"id":"10.13039\/100009666","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Banyu Foundation Research Grant"},{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.bbrc.2013.10.129","type":"journal-article","created":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T11:03:49Z","timestamp":1383303829000},"page":"544-549","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Treatment with 17-allylamino-17-demethoxygeldanamycin ameliorated symptoms of Bartter syndrome type IV caused by mutated Bsnd in mice"],"prefix":"10.1016","volume":"441","author":[{"given":"Naohiro","family":"Nomura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazusaku","family":"Kamiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuhisa","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naofumi","family":"Yui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motoko","family":"Chiga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eisei","family":"Sohara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatemitu","family":"Rai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sei","family":"Sakaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinich","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2013.10.129_b0005","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/ng752","article-title":"Mutation of BSND causes Bartter syndrome with sensorineural deafness and kidney failure","volume":"29","author":"Birkenh\u00e4ger","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbrc.2013.10.129_b0010","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/35107099","article-title":"Barttin is a Cl\u2212 channel beta-subunit crucial for renal Cl\u2212 reabsorption and inner ear K+ secretion","volume":"414","author":"Est\u00e9vez","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2013.10.129_b0015","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1172\/JCI117626","article-title":"Localization and functional characterization of rat kidney-specific chloride channel, ClC-K1","volume":"95","author":"Uchida","year":"1995","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbrc.2013.10.129_b0020","doi-asserted-by":"crossref","first-page":"3821","DOI":"10.1016\/S0021-9258(18)53545-6","article-title":"Molecular cloning of a chloride channel that is regulated by dehydration and expressed predominantly in kidney medulla","volume":"268","author":"Uchida","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2013.10.129_b0025","first-page":"F552","article-title":"Localization of rat CLC-K2 chloride channel mRNA in the kidney","volume":"276","author":"Yoshikawa","year":"1999","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.bbrc.2013.10.129_b0030","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1681\/ASN.V1271327","article-title":"Intrarenal and cellular localization of CLC-K2 protein in the mouse kidney","volume":"12","author":"Kobayashi","year":"2001","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bbrc.2013.10.129_b0035","doi-asserted-by":"crossref","first-page":"17677","DOI":"10.1016\/S0021-9258(17)32494-8","article-title":"Two isoforms of a chloride channel predominantly expressed in thick ascending limb of Henle\u2019s loop and collecting ducts of rat kidney","volume":"269","author":"Adachi","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2013.10.129_b0040","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1038\/emboj.2008.203","article-title":"Endocochlear potential depends on Cl\u2212 channels: mechanism underlying deafness in Bartter syndrome IV","volume":"27","author":"Rickheit","year":"2008","journal-title":"EMBO J."},{"key":"10.1016\/j.bbrc.2013.10.129_b0045","doi-asserted-by":"crossref","first-page":"F297","DOI":"10.1152\/ajprenal.00604.2010","article-title":"Generation and analyses of R8L barttin knockin mouse","volume":"301","author":"Nomura","year":"2011","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.bbrc.2013.10.129_b0050","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1152\/physiol.00023.2006","article-title":"Molecular and physiological bases of the K+ circulation in the mammalian inner ear","volume":"21","author":"Hibino","year":"2006","journal-title":"Physiology (Bethesda)"},{"key":"10.1016\/j.bbrc.2013.10.129_b0055","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1113\/jphysiol.2006.112888","article-title":"Supporting sensory transduction: cochlear fluid homeostasis and the endocochlear potential","volume":"576","author":"Wangemann","year":"2006","journal-title":"J. Physiol."},{"key":"10.1016\/j.bbrc.2013.10.129_b0060","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1073\/pnas.0711463105","article-title":"The endocochlear potential depends on two K+ diffusion potentials and an electrical barrier in the stria vascularis of the inner ear","volume":"105","author":"Nin","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbrc.2013.10.129_b0065","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s00467-008-1008-6","article-title":"Deletion of exons 2\u20134 in the BSND gene causes severe antenatal Bartter syndrome","volume":"24","author":"Bircan","year":"2009","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.bbrc.2013.10.129_b0070","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1007\/s00467-006-0108-4","article-title":"Barttin mutations in antenatal Bartter syndrome with sensorineural deafness","volume":"21","author":"Ozlu","year":"2006","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.bbrc.2013.10.129_b0075","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1210\/jc.2002-021398","article-title":"Atypical Bartter syndrome with sensorineural deafness with G47R mutation of the beta-subunit for ClC-Ka and ClC-Kb chloride channels, barttin","volume":"88","author":"Miyamura","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbrc.2013.10.129_b0080","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s00467-006-0062-1","article-title":"Mutation G47R in the BSND gene causes Bartter syndrome with deafness in two Spanish families","volume":"21","author":"Garc\u00eda-Nieto","year":"2006","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.bbrc.2013.10.129_b0085","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ajhg.2009.07.003","article-title":"Molecular basis of DFNB73: mutations of BSND can cause nonsyndromic deafness or Bartter syndrome","volume":"85","author":"Riazuddin","year":"2009","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbrc.2013.10.129_b0090","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s00467-005-2091-6","article-title":"A compound heterozygous mutation in the BSND gene detected in Bartter syndrome type IV","volume":"21","author":"Kitanaka","year":"2006","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.bbrc.2013.10.129_b0095","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1007\/s00467-006-0090-x","article-title":"Type IV Bartter syndrome: report of two new cases","volume":"21","author":"Zaffanello","year":"2006","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.bbrc.2013.10.129_b0100","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1093\/ndt\/gfl493","article-title":"Unusual adult-onset manifestation of an attenuated Bartter\u2019s syndrome type IV renal phenotype caused by a mutation in BSND","volume":"22","author":"Brum","year":"2007","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.bbrc.2013.10.129_b0105","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s00424-002-0819-8","article-title":"Barttin increases surface expression and changes current properties of ClC-K channels","volume":"444","author":"Waldegger","year":"2002","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.bbrc.2013.10.129_b0110","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s00418-003-0535-2","article-title":"Molecular mechanisms of Bartter syndrome caused by mutations in the BSND gene","volume":"119","author":"Hayama","year":"2003","journal-title":"Histochem. Cell Biol."},{"key":"10.1016\/j.bbrc.2013.10.129_b0115","doi-asserted-by":"crossref","first-page":"L52","DOI":"10.1152\/ajplung.2001.281.1.L52","article-title":"Partial restoration of defective chloride conductance in DeltaF508 CF mice by trimethylamine oxide","volume":"281","author":"Fischer","year":"2001","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.bbrc.2013.10.129_b0120","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1074\/jbc.271.2.635","article-title":"Glycerol reverses the misfolding phenotype of the most common cystic fibrosis mutation","volume":"271","author":"Sato","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2013.10.129_b0125","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1126\/science.1093941","article-title":"Curcumin, a major constituent of turmeric, corrects cystic fibrosis defects","volume":"304","author":"Egan","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2013.10.129_b0130","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1379\/1466-1268(1996)001<0117:CCCTMP>2.3.CO;2","article-title":"Chemical chaperones correct the mutant phenotype of the delta F508 cystic fibrosis transmembrane conductance regulator protein","volume":"1","author":"Brown","year":"1996","journal-title":"Cell Stress Chaperones"},{"key":"10.1016\/j.bbrc.2013.10.129_b0135","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1172\/JCI2303","article-title":"Defective aquaporin-2 trafficking in nephrogenic diabetes insipidus and correction by chemical chaperones","volume":"101","author":"Tamarappoo","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbrc.2013.10.129_b0140","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1096\/fj.08-118422","article-title":"Hsp90 inhibitor partially corrects nephrogenic diabetes insipidus in a conditional knock-in mouse model of aquaporin-2 mutation","volume":"23","author":"Yang","year":"2009","journal-title":"FASEB J."},{"key":"10.1016\/j.bbrc.2013.10.129_b0145","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1172\/JCI8688","article-title":"Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutants","volume":"105","author":"Morello","year":"2000","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbrc.2013.10.129_b0150","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1681\/ASN.2005080854","article-title":"Pharmacologic chaperones as a potential treatment for X-linked nephrogenic diabetes insipidus","volume":"17","author":"Bernier","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bbrc.2013.10.129_b0155","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s00418-003-0511-x","article-title":"Intracellular mislocalization of mutant podocin and correction by chemical chaperones","volume":"119","author":"Ohashi","year":"2003","journal-title":"Histochem. Cell Biol."},{"key":"10.1016\/j.bbrc.2013.10.129_b0160","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1074\/jbc.M111.283036","article-title":"Molecular and cellular effects of Tamm\u2013Horsfall protein mutations and their rescue by chemical chaperones","volume":"287","author":"Ma","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2013.10.129_b0165","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1016\/j.febslet.2012.06.023","article-title":"Roles of 17-AAG-induced molecular chaperones and Rma1 E3 ubiquitin ligase in folding and degradation of pendrin","volume":"586","author":"Lee","year":"2012","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbrc.2013.10.129_b0170","doi-asserted-by":"crossref","first-page":"C1389","DOI":"10.1152\/ajpcell.00098.2009","article-title":"FAPP2 is required for aquaporin-2 apical sorting at trans-Golgi network in polarized MDCK cells","volume":"297","author":"Yui","year":"2009","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.bbrc.2013.10.129_b0175","doi-asserted-by":"crossref","first-page":"214","DOI":"10.2353\/ajpath.2007.060948","article-title":"Mesenchymal stem cell transplantation accelerates hearing recovery through the repair of injured cochlear fibrocytes","volume":"171","author":"Kamiya","year":"2007","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbrc.2013.10.129_b0180","first-page":"F678","article-title":"Localization and induction by dehydration of ClC-K chloride channels in the rat kidney","volume":"272","author":"Vandewalle","year":"1997","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.bbrc.2013.10.129_b0185","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1681\/ASN.2008010102","article-title":"Disease-causing dysfunctions of barttin in Bartter syndrome type IV","volume":"20","author":"Janssen","year":"2009","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bbrc.2013.10.129_b0190","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0065-230X(06)95009-X","article-title":"Inhibitors of the Hsp90 molecular chaperone: current status","volume":"95","author":"Sharp","year":"2006","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/j.bbrc.2013.10.129_b0195","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1042\/BJ20071640","article-title":"The Hsp90 molecular chaperone: an open and shut case for treatment","volume":"410","author":"Pearl","year":"2008","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbrc.2013.10.129_b0200","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3816\/CLML.2011.n.002","article-title":"Tanespimycin as antitumor therapy","volume":"11","author":"Dimopoulos","year":"2011","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"10.1016\/j.bbrc.2013.10.129_b0205","doi-asserted-by":"crossref","first-page":"4152","DOI":"10.1200\/JCO.2005.00.612","article-title":"Phase I pharmacokinetic and pharmacodynamic study of 17-allylamino, 17-demethoxygeldanamycin in patients with advanced malignancies","volume":"23","author":"Banerji","year":"2005","journal-title":"J. Clin. Oncol."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X13018226?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X13018226?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,11]],"date-time":"2022-03-11T11:44:50Z","timestamp":1646999090000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X13018226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0006291X13018226"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2013.10.129","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment with 17-allylamino-17-demethoxygeldanamycin ameliorated symptoms of Bartter syndrome type IV caused by mutated Bsnd in mice","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2013.10.129","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}